Curriculum Vitae

Nama : Dr. Ronald Irwanto Natadidjaja, SpPD – KPTI, FINASIM

Pendidikan :
SMP - SMA : Kolese KANISIUS, 1994
Dokter Umum : FK TRISAKTI, 2002
Spesialis Penyakit Dalam (Internist) : FKUI, 2009
Konsultan Penyakit Tropik & Infeksi : FKUI / PAPDI, 2013

Pekerjaan :
Bendahara Pengurus Besar Perhimpunan Konsultan Penyakit Tropik dan Infeksi Indonesia (PB PETRI)

SekJen Pengurus Pusat Perhimpunan Pengendalian Infeksi Indonesia (PP. PERDALIN)

Tim Panel Ahli PNPK Sepsis, Kemenkes RI

Anggota Pokja PPI, Kemenkes RI

Staf Pengajar Ilmu Penyakit Dalam, FK TRISAKTI

Ketua PPRA, RS PONDOK INDAH – PURI INDAH dan RS PONDOK INDAH – BINTARO JAYA

Wakil Ketua Komite Medik, RS PONDOK INDAH – PURI INDAH

Internist - Konsultan, RS PONDOK INDAH – PURI INDAH dan RS PONDOK INDAH – BINTARO JAYA
MANAJEMEN KLB

Ronald Irwanto
PP.PERDALIN
POKJA PPI KEMENKES
 INTERNIST - INFECTIOUS DISEASE (ID) CONSULTANT
Tropical Disease Infectious Disease
• Bacterial Acute Diarrhea  Surgical Prophylaxis
• Typhoid Fever  Pneumonia, CAP/HAP/VAP
 cIAI
• Leptospirosis
 Urinary Tract Infection
• Tuberculosis
 SSTIs
• Amebiasis  Primary BSIs
NON ANTIBIOTIC USAGE  Sepsis
Dengue  Febrile Neutropenia
Chikungunya  HIV + Opportunistic Infection
Measles
Pox  MDR/XDR/PDR Issue

EMERGING INFECTIOUS DISEASE :

AVIAN INFLUENZA
SWINE FLU
SARS / MERS CO-V
EBOLA
 KLB
• Peningkatan jumlah
insidensi (Surveillance) ACTION PLAN
• Kejadian pertama kali
ISSUE :
HAIs Incidence Rate (Surveillance)
Multi Drug Resistance (MDR)
Extensively Drug Resistance (XDR)
Pan Drug Resistance (PDR)
AAD-CDAD, C.difficle infection

Emerging Infectious Disease :

SARS, MERS-CoV, H5N1, H1N1, Diphteria
 Resistance in Gram-negatives
• MDR (multidrug-resistant)
– Resistance to 3 classes of antimicrobial agents
• CR( carbapenems resistant)
– Resistant to imipenem or meropenem
• XDR (extensively drug-resistant)
– Resistance to all but 1 or 2 (colistin or
tigecycline)
• PDR (pandrug-resistant)
– Resistance to all*
*Antimicrobial agents that are available at the time of use of the
definition and in most parts of the world and that are regarded as
potentially effective against the respective pathogens
Falagas ME et al. Clin Infect Dis 2008;41:848-54.
 Campaign to Prevent Antimicrobial Resistance in Healthcare Settings

Emergence of Antimicrobial Resistance

Susceptible Bacteria

Resistant Bacteria

Mutations

Resistance Gene Transfer

New Resistant Bacteria
 MANAJEMEN KLB
• PENCEGAHAN / SCREENING
• DETEKSI
• ISOLASI
• Kewaspadaan Isolasi (Standar+Berdasar
Transmisi)
• EVALUASI
Screening / Pencegahan
Pro Screening :
Sensitivitas Tinggi-Spesifisitas Rendah

Berbeda dengan

Pro Diagnostik
Sensitivitas Rendah-Spesifisitas Tinggi
 Isolasi
CONTOH : & Tatalaksana Difteri
SCREENING DIFTERI/
Kultur Diagnostik PRO
DIAGNOSTIC

Pseudomembran (+)
+
PRO ISOLASI
SCREENING Swab Screening
Demam Albert / Neisser
Sakit Tenggorokan
Batuk / Pilek tidak menonjol
Leukosit tinggi
-
Pseudomembran (-)

Leukosit rendah/normal DIFTERI (-)

DETEKSI
• Peningkatan jumlah
insidensi
• Kejadian pertama kali
ISOLASI
• BSL3
High Virulence + High Pathogenecity
- MRSA
-Tuberculosis
- Measles, Pox
KEWASPADAAN STANDAR
&
KEWASPADAAN BERDASAR TRANSMISI
EVALUASI
Evaluasi Kondisi : Evaluasi Fungsional:
Host Sistem
Agent Proses
Environment Produk
Finansial
Fasilitas
SDM
KEWASPADAAN STANDAR
&
KEWASPADAAN BERDASAR TRANSMISI
TERIMA KASIH